Sign in

Colorectal cancer: trials that stopped early

Trials on Colorectal cancer that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.

Stopped early

254 stopped trials give a reason in the registry, latest registry update first. 4 more give no reason and are not listed.

  1. Terminated

    A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors

    Reason given in the registry

    “Corporate decision”

    Quoted unchanged from ClinicalTrials.gov; record updated 8 May 2024.

    Ended
    Apr 2024
    Phase
    Phase 1/2
    Run by
    Medikine, Inc.
    Registry record
    NCT05716295
  2. Terminated

    First-line Maintenance of OH2 Injection for Advanced Colorectal Cancer

    Reason given in the registry

    “Strategy adjustment”

    Quoted unchanged from ClinicalTrials.gov; record updated 30 Apr 2024.

    Ended
    Apr 2024
    Phase
    Phase 2
    Run by
    Binhui Biopharmaceutical Co., Ltd.
    Registry record
    NCT05648006
  3. Withdrawn

    Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)

    Reason given in the registry

    “0 participant accrual”

    Quoted unchanged from ClinicalTrials.gov; record updated 29 Apr 2024.

    Ended
    Feb 2024
    Phase
    Phase 2
    Run by
    M.D. Anderson Cancer Center
    Registry record
    NCT05900648
  4. Terminated

    TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)

    Reason given in the registry

    “failure to accrue”

    Quoted unchanged from ClinicalTrials.gov; record updated 26 Apr 2024.

    Ended
    Apr 2024
    Phase
    Phase 1
    Run by
    Abramson Cancer Center at Penn Medicine
    Registry record
    NCT04873895
  5. Terminated

    "Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.

    Reason given in the registry

    “Suspicion of adverse events”

    Quoted unchanged from ClinicalTrials.gov; record updated 24 Apr 2024.

    Ended
    Apr 2024
    Run by
    Helse Stavanger HF
    Registry record
    NCT03402477
  6. Terminated

    Exercise Intervention Prior to CRS-HIPEC: Feasibility & Impact

    Reason given in the registry

    “Difficulty enrolling and we lost exercise specialist”

    Quoted unchanged from ClinicalTrials.gov; record updated 17 Apr 2024.

    Ended
    Dec 2023
    Run by
    Milton S. Hershey Medical Center
    Registry record
    NCT04731441
  7. Withdrawn

    Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer

    Reason given in the registry

    “Sponsor already published research that was to be obtained from this study.”

    Quoted unchanged from ClinicalTrials.gov; record updated 12 Apr 2024.

    Ended
    Jun 2024
    Run by
    Case Comprehensive Cancer Center
    Registry record
    NCT05356585
  8. Suspended

    DNX-2440 for Resectable Colorectal Liver Metastasis

    Reason given in the registry

    “DNAtrix management decision not based on study design, safety, or site performance.”

    Quoted unchanged from ClinicalTrials.gov; record updated 9 Apr 2024.

    Phase
    Phase 1
    Run by
    DNAtrix, Inc.
    Registry record
    NCT04714983
  9. Suspended

    Point of Care, Real-Time Urine Metabolomics Test to Diagnose Colorectal Cancers and Polyps in Low-and Middle-Income Countries

    Reason given in the registry

    “The urine POC device seems not to be promising in colorectal cancer screening”

    Quoted unchanged from ClinicalTrials.gov; record updated 5 Apr 2024.

    Ended
    Mar 2025
    Run by
    Obafemi Awolowo University Teaching Hospital
    Registry record
    NCT05679960
  10. Withdrawn

    The Effects of Chiropractic in Adults With Colon Cancer

    Reason given in the registry

    “Low recruitment rate”

    Quoted unchanged from ClinicalTrials.gov; record updated 3 Apr 2024.

    Ended
    Mar 2025
    Run by
    Life University
    Registry record
    NCT05310565
  11. Withdrawn

    #CuttingCRC: Barbershop-Based Trial & Colorectal Cancer

    Reason given in the registry

    “PI no longer employed at institutuion”

    Quoted unchanged from ClinicalTrials.gov; record updated 22 Mar 2024.

    Ended
    Feb 2024
    Run by
    Medical College of Wisconsin
    Registry record
    NCT03733197
  12. Terminated

    A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)

    Reason given in the registry

    “sponsor decision”

    Quoted unchanged from ClinicalTrials.gov; record updated 8 Mar 2024.

    Ended
    Mar 2024
    Phase
    Phase 1
    Run by
    HiberCell, Inc.
    Registry record
    NCT05121948
  13. Withdrawn

    Medial Border of Laparoscopic D3 Lymphadenectomy for Right Colon Cancer

    Reason given in the registry

    “no funds”

    Quoted unchanged from ClinicalTrials.gov; record updated 26 Feb 2024.

    Ended
    Oct 2025
    Run by
    Shanghai Minimally Invasive Surgery Center
    Registry record
    NCT04518449
  14. Terminated

    Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma

    Reason given in the registry

    “Sponsor decision (not due to safety concerns)”

    Quoted unchanged from ClinicalTrials.gov; record updated 30 Jan 2024.

    Ended
    Jan 2024
    Phase
    Phase 1
    Run by
    Stingthera, Inc.
    Registry record
    NCT04609579
  15. Withdrawn

    Safety and Efficacy Study of Chemotherapy Plus Apatinib as Second-line Therapy in Metastatic Colorectal Cancer

    Reason given in the registry

    “Inadequate patient enrollment”

    Quoted unchanged from ClinicalTrials.gov; record updated 3 Jan 2024.

    Ended
    Dec 2024
    Phase
    Phase 2
    Run by
    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    Registry record
    NCT03193814
  16. Suspended

    Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer

    Reason given in the registry

    “Inadequate patient enrollment”

    Quoted unchanged from ClinicalTrials.gov; record updated 3 Jan 2024.

    Ended
    Dec 2023
    Phase
    Phase 1/2
    Run by
    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    Registry record
    NCT04558684
  17. Withdrawn

    Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer

    Reason given in the registry

    “Issues recruiting”

    Quoted unchanged from ClinicalTrials.gov; record updated 22 Dec 2023.

    Ended
    Sept 2026
    Phase
    Early phase 1
    Run by
    Roswell Park Cancer Institute
    Registry record
    NCT04870034
  18. Withdrawn

    A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)

    Reason given in the registry

    “This clinical trial was not finally approved by the Korea FDA.”

    Quoted unchanged from ClinicalTrials.gov; record updated 31 Oct 2023.

    Ended
    Aug 2024
    Phase
    Phase 1/2
    Run by
    Korean Cancer Study Group
    Registry record
    NCT04751955
  19. Withdrawn

    CPI-613 (Devimistat) in Combination With Modified FOLFIRINOX Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

    Reason given in the registry

    “no funding”

    Quoted unchanged from ClinicalTrials.gov; record updated 13 Sept 2023.

    Ended
    Nov 2024
    Phase
    Phase 1
    Run by
    Cornerstone Pharmaceuticals
    Registry record
    NCT05070104
  20. Suspended

    Biomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C)

    Reason given in the registry

    “Too slow speed for recruiting.”

    Quoted unchanged from ClinicalTrials.gov; record updated 29 Jun 2023.

    Run by
    Shenzhen People's Hospital
    Registry record
    NCT03743428
  21. Withdrawn

    Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers

    Reason given in the registry

    “Study never started/ will not proceed.”

    Quoted unchanged from ClinicalTrials.gov; record updated 7 Jun 2023.

    Ended
    Apr 2025
    Phase
    Phase 2
    Run by
    Translational Research in Oncology
    Registry record
    NCT05582031
  22. Withdrawn

    Gastrointestinal Anastomosis Using MonoPlus® Suture

    Reason given in the registry

    “The GASTROMO study has been stopped early before enrolling its first patient because the results of our primary endpoint would have been inconsistent. The variability of the leakage rate between all anastomosis included in the study was overly high.”

    Quoted unchanged from ClinicalTrials.gov; record updated 5 Apr 2023.

    Ended
    Dec 2023
    Run by
    Aesculap AG
    Registry record
    NCT04811833
  23. Withdrawn

    Predicting Risk for Post-polypectomy Colorectal Cancer

    Reason given in the registry

    “Alternative method of implementation, study not needed”

    Quoted unchanged from ClinicalTrials.gov; record updated 28 Feb 2023.

    Ended
    Dec 2023
    Run by
    Kaiser Permanente
    Registry record
    NCT05606081
  24. Suspended

    Guangzhou Women's Health Cohort Study (GWHCS)

    Reason given in the registry

    “Due to the rebound of the COVID-19 epidemic in the city, we have to suspend the project temporarily.”

    Quoted unchanged from ClinicalTrials.gov; record updated 23 Feb 2023.

    Ended
    Aug 2026
    Run by
    Guangzhou Women and Children's Medical Center
    Registry record
    NCT05506800
  25. Withdrawn

    Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors

    Reason given in the registry

    “Similar clinical trials showed not very encouraging results, which made us decide, after several modifications to the protocol and numerous difficulties encountered, to abandon the trial.”

    Quoted unchanged from ClinicalTrials.gov; record updated 26 Jan 2023.

    Ended
    Dec 2024
    Phase
    Phase 2
    Run by
    Gustave Roussy, Cancer Campus, Grand Paris
    Registry record
    NCT03982173
  26. Suspended

    Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer

    Reason given in the registry

    “The efficacy evaluation (based on current data) deviated too much from results of previous clinical trials. It's assumed that high dropout rate of subjects, mainly due to covid-19 epidemic in China in the past 3 years, is the main reason.”

    Quoted unchanged from ClinicalTrials.gov; record updated 10 Jan 2023.

    Ended
    Dec 2024
    Phase
    Phase 2
    Run by
    Beijing Biostar Pharmaceuticals Co., Ltd.
    Registry record
    NCT03906565
  27. Withdrawn

    Local Consolidative Therapy in Colorectal Cancer

    Reason given in the registry

    “Study is being closed due to lack of accrual”

    Quoted unchanged from ClinicalTrials.gov; record updated 9 Dec 2022.

    Ended
    Oct 2025
    Phase
    Phase 2
    Run by
    Fox Chase Cancer Center
    Registry record
    NCT05062720
  28. Withdrawn

    Managing Colorectal Cancer Prevention Procedure Wait Lists During the COVID-19 Pandemic

    Reason given in the registry

    “The study was never started due to lack of staff”

    Quoted unchanged from ClinicalTrials.gov; record updated 29 Nov 2022.

    Ended
    Dec 2023
    Run by
    Centre hospitalier de l'Université de Montréal (CHUM)
    Registry record
    NCT04964596
  29. Withdrawn

    A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy

    Reason given in the registry

    “Study drug not available for the study duration.”

    Quoted unchanged from ClinicalTrials.gov; record updated 4 Nov 2022.

    Phase
    Phase 2
    Run by
    NSABP Foundation Inc
    Registry record
    NCT05178576
  30. Withdrawn

    Improving Survivorship Among Minority Cancer Dyads

    Reason given in the registry

    “Study not funded”

    Quoted unchanged from ClinicalTrials.gov; record updated 26 Jul 2022.

    Ended
    Dec 2024
    Run by
    Charles Drew University of Medicine and Science
    Registry record
    NCT04685551

Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.